{
    "id": "professional_medicine-057",
    "question": "A 3-year-old boy with chronic granulomatous disease is brought to the physician because of a 3-week history of fever and warm, red lumps under both arms. His temperature is 38\u00b0C (100.4\u00b0F). Physical examination shows enlarged, 3-cm, erythematous axillary lymph nodes bilaterally. On palpation, the nodes are tender, fluctuant, and movable. Examination of a fine-needle aspirate from one of the nodes shows gram-positive cocci in clusters. Cultures of the aspirate grow yellow, \u03b2hemolytic colonies that are catalase and coagulase positive. A polymerase chain reaction test shows mecA-positive organisms. Which of the following is the most appropriate pharmacotherapy for this patient?",
    "options": {
        "A": "Ciprofloxacin",
        "B": "Penicillin G",
        "C": "Rifampin",
        "D": "Vancomycin"
    },
    "answer": "D",
    "predict": "To approach this question, let's break it down step by step: 1. **Clinical Presentation**: The patient is a 3-year-old boy with fever and erythematous, fluctuant, tender axillary lymph nodes. This presentation is suggestive of a skin and soft tissue infection. 2. **Laboratory Findings**: - The fine-needle aspirate shows gram-positive cocci in clusters, which is indicative of Staphylococcus species. - The cultures grow yellow, \u03b2-hemolytic colonies that are catalase and coagulase positive. This further supports the identification of Staphylococcus aureus, as it is known for being catalase and coagulase positive. - The polymerase chain reaction (PCR) test shows mecA-positive organisms, which is a specific gene that is commonly associated with methicillin-resistant Staphylococcus aureus (MRSA). 3. **Chronic Granulomatous Disease (CGD)**: This is an immunodeficiency disorder characterized by the inability of phagocytic cells to kill certain bacteria, including Staphylococcus aureus. Patients with CGD are more susceptible to severe infections, including those caused by MRSA. 4. **Pharmacotherapy Considerations**: - **A. Ciprofloxacin**: This is a fluoroquinolone antibiotic, which may not be the most effective choice for MRSA infections. - **B. Penicillin G**: This is a beta-lactam antibiotic that is ineffective against MRSA due to its susceptibility to beta-lactamase degradation. - **C. Rifampin**: This is an antibiotic that can be used for MRSA treatment but is not the first-line treatment for skin and soft tissue infections. - **D. Vancomycin**: This is a glycopeptide antibiotic that is effective against MRSA and is often used as the first-line treatment for serious MRSA infections, including skin and soft tissue infections. Given the presence of MRSA and the clinical presentation of a skin and soft tissue infection, the most appropriate pharmacotherapy for this patient is vancomycin. **Output**: ```json { \"step_by_step_thinking\": \"The patient's presentation and laboratory findings suggest a Staphylococcus aureus infection, specifically MRSA, in a patient with chronic granulomatous disease. Given the severity of the infection and the patient's immunocompromised state, vancomycin is the most appropriate pharmacotherapy choice.\", \"answer_choice\": \"D\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 58.68113160133362
}